Ligand validation:2WJM

MQ7: MENAQUINONE-7

MQ7 is a Ligand Of Interest in 2WJM designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2WJM_MQ7_M_404	66%	34%	0.118	0.922	1.44	1.18	2	6	0	0	100%	1
6PRC_MQ7_M_501	100%	25%	0.038	0.98	1.77	1.32	12	9	0	0	100%	1
5PRC_MQ7_M_501	100%	22%	0.038	0.978	1.72	1.52	12	10	0	0	100%	1
3PRC_MQ7_M_501	99%	28%	0.045	0.977	1.57	1.31	9	8	0	0	100%	1
2PRC_MQ7_M_501	98%	26%	0.047	0.972	1.71	1.31	17	5	0	0	100%	1
7PRC_MQ7_M_501	98%	23%	0.05	0.969	1.51	1.65	12	14	1	0	100%	1
1PRC_MQ7_M_608	97%	14%	0.054	0.97	1.44	2.37	5	21	1	0	100%	0.9167

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.